1-[[6-(6,6-difluoro-3-azabicyclo[3.1.0]hexan-3-yl)-2,4-dimethyl-3-pyridinyl]methyl]pyrazole-4-carboxylic acid
C17H18F2N4O2 — CID 156825987
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[[6-(6,6-difluoro-3-azabicyclo[3.1.0]hexan-3-yl)-2,4-dimethyl-3-pyridinyl]methyl]pyrazole-4-carboxylic acid
1-[[6-(6,6-difluoro-3-azabicyclo[3.1.0]hexan-3-yl)-2,4-dimethyl-3-pyridinyl]methyl]pyrazole-4-carboxylic acid (PubChem CID 156825987) has the molecular formula C17H18F2N4O2 and a molecular weight of 348.35 g/mol. Its IUPAC name is 1-[[6-(6,6-difluoro-3-azabicyclo[3.1.0]hexan-3-yl)-2,4-dimethyl-3-pyridinyl]methyl]pyrazole-4-carboxylic acid.
Molecular Properties
| Compound Name | 1-[[6-(6,6-difluoro-3-azabicyclo[3.1.0]hexan-3-yl)-2,4-dimethyl-3-pyridinyl]methyl]pyrazole-4-carboxylic acid |
|---|---|
| PubChem CID | 156825987 |
| Molecular Formula | C17H18F2N4O2 |
| Molecular Weight | 348.35 g/mol |
| Exact Mass | 348.14 |
| IUPAC Name | 1-[[6-(6,6-difluoro-3-azabicyclo[3.1.0]hexan-3-yl)-2,4-dimethyl-3-pyridinyl]methyl]pyrazole-4-carboxylic acid |
| SMILES | Cc1cc(N2CC3C(C2)C3(F)F)nc(C)c1Cn1cc(C(=O)O)cn1 |
| InChI | InChI=1S/C17H18F2N4O2/c1-9-3-15(22-7-13-14(8-22)17(13,18)19)21-10(2)12(9)6-23-5-11(4-20-23)16(24)25/h3-5,13-14H,6-8H2,1-2H3,(H,24,25) |
| InChIKey | VQYKKCQSQRMDBJ-UHFFFAOYSA-N |
| XLogP | 2.34 |
| TPSA | 71.25 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 25 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 348.35 |
| LogP ≤ 5 | 2.34 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 156825987 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.